Inicio | Buscar

Buscar

Resultados de la búsqueda

NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.

... 1st degree specialist in oncology Affiliation:  ... Dra. Ana de la Torre Santos. 2nd degree specialist in oncology Holguin, Vladimir ...

Clinical Trials - CIM - 07/07/2017 - 10:36am

Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors.

... 2nd degree specialist in oncology Affiliation:  National Institute of Oncology and Radiobiology Postal ...

Clinical Trials - CIM - 05/07/2017 - 8:26am

99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II

... 1st degree specialist in oncology Affiliation:  ...

Clinical Trials - CIM - 04/07/2017 - 4:33pm

NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II

... 2nd degree specialist in oncology Affiliation:  ... Havana, National Institute of Oncology and Radiobiology (INOR), Ronald Rodríguez Diaz, MD. 2nd degree ...

Clinical Trials - CIM - 04/07/2017 - 4:07pm

Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I.

... 2nd degree specialist in oncology Affiliation:  ...

Clinical Trials - CIM - 23/06/2017 - 4:50pm

Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III.

... 2nd degree specialist in oncology. Affiliation:  National Institute of Oncology and Radiobiology Postal ...

Clinical Trials - CIM - 19/06/2017 - 11:19am

InCCNM -I

... Specialist in Oncology and Radiobiology Affiliation:  ... National Institute of Oncology and Radiobiology Postal ...

Clinical Trials - CIGB - 19/06/2017 - 10:13am

Efecto y seguridad del ior® EPOCIM en pacientes con Linfoma No Hodgkin tratados con antraciclinas.

... light at the end of the tunnel?. Editorial. Annals of Oncology. 2002; 13: 647-649. 7.Cvetkovic RS, Scott LJ. Dexrazoxane a review of ... Therapy for Lymphoma in Adults. Journal of Clinical Oncology 2004; 22 (10):1864-1871. 18.Lipshultz SE, Colan SD, Gelber RD, ...

Ensayos Clínicos - CIMAB - 01/06/2017 - 5:31pm

iorEPOCIM-Infarto cerebral agudo-Fase I

... malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997;15:1218-34. ... practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 2002; 100(7): 2303-2320. ...

Ensayos Clínicos - CIMAB - 01/06/2017 - 3:59pm

''Evaluación de la seguridad de la Eritropoyetina Humana Recombinante, ior EPOCIM, en el tratamiento de pacientes con Infarto Cerebral Agudo. Estudio Fase I''.

... malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997;15:1218-34. ... practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 2002; 100(7): 2303-2320. ...

Ensayos Clínicos - CIMAB - 01/06/2017 - 2:32pm